药易购
(300937)
| 流通市值：14.29亿 | | | 总市值：21.82亿 |
| 流通股本：6264.79万 | | | 总股本：9566.67万 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,237,408,296.37 | 4,430,412,450.51 | 3,212,357,594.74 | 2,204,845,065.75 |
| 营业收入 | 1,237,408,296.37 | 4,430,412,450.51 | 3,212,357,594.74 | 2,204,845,065.75 |
| 二、营业总成本 | 1,215,251,341.39 | 4,344,720,824.45 | 3,132,067,147.14 | 2,132,672,717.94 |
| 营业成本 | 1,136,598,621.14 | 4,062,812,564.02 | 2,924,146,519.71 | 1,994,456,081.93 |
| 税金及附加 | 1,878,781.2 | 7,500,955.81 | 5,003,347.59 | 3,553,998.03 |
| 销售费用 | 53,858,024.16 | 190,621,758.5 | 143,155,370.65 | 94,603,268.16 |
| 管理费用 | 16,035,880.23 | 57,472,198.28 | 42,071,281.81 | 28,737,999.63 |
| 研发费用 | 4,797,456.92 | 19,320,715.88 | 14,122,063.35 | 9,222,113.48 |
| 财务费用 | 2,082,577.74 | 6,992,631.96 | 3,568,564.03 | 2,099,256.71 |
| 其中:利息费用 | 2,496,778.82 | 6,582,689.83 | 4,410,068.34 | 2,290,815.89 |
| 其中:利息收入 | 1,084,694.81 | 2,268,446.49 | 2,696,419.23 | 1,578,115.22 |
| 加:投资收益 | -20,452.37 | 1,540,241.15 | 403,817.23 | 408,561.78 |
| 资产处置收益 | -31,613.64 | -52,690.45 | 1,417.18 | 3,526.82 |
| 资产减值损失(新) | 636,781.83 | -9,093,615.87 | -2,794,608.04 | -1,198,892.71 |
| 信用减值损失(新) | -17,055,956.13 | -13,159,533.04 | -21,004,426.79 | -18,490,615.91 |
| 其他收益 | 761,647.73 | 3,672,019.48 | 3,148,593.67 | 2,932,439.2 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 6,447,362.4 | 68,598,047.33 | 60,045,240.85 | 55,827,366.99 |
| 加:营业外收入 | 65,888.42 | 1,655,279.73 | 1,456,103.76 | 1,393,111.52 |
| 减:营业外支出 | 110,265.68 | 371,454.25 | 187,647.58 | 231,066.5 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 6,402,985.14 | 69,881,872.81 | 61,313,697.03 | 56,989,412.01 |
| 减:所得税费用 | -791,181.36 | 13,108,246.39 | 11,667,976.73 | 10,335,438.91 |
| 六、净利润 | 7,194,166.5 | 56,773,626.42 | 49,645,720.3 | 46,653,973.1 |
| 持续经营净利润 | 7,194,166.5 | 56,773,626.42 | 51,987,158.48 | 46,653,973.1 |
| 终止经营净利润 | - | - | -2,341,438.18 | - |
| 归属于母公司股东的净利润 | 9,225,531.31 | 59,532,026.96 | 50,157,269.26 | 46,717,668.57 |
| 少数股东损益 | -2,031,364.81 | -2,758,400.54 | -511,548.96 | -63,695.47 |
| (一)基本每股收益 | 0.1 | 0.62 | 0.52 | 0.49 |
| (二)稀释每股收益 | 0.1 | 0.62 | 0.52 | 0.49 |
| 八、其他综合收益 | - | 1,497,000 | 1,497,000 | 1,497,000 |
| 归属于母公司股东的其他综合收益 | - | 1,497,000 | 1,497,000 | 1,497,000 |
| 九、综合收益总额 | 7,194,166.5 | 58,270,626.42 | 51,142,720.3 | 48,150,973.1 |
| 归属于母公司股东的综合收益总额 | 9,225,531.31 | 61,029,026.96 | 51,654,269.26 | 48,214,668.57 |
| 归属于少数股东的综合收益总额 | -2,031,364.81 | -2,758,400.54 | -511,548.96 | -63,695.47 |
| 公告日期 | 2024-04-25 | 2024-04-10 | 2023-10-28 | 2023-08-23 |
| 审计意见(境内) | | 标准无保留意见 | | |